NCT06650358
Clinical Outcomes of Patients with LAL+ in At Least One Eye
Enrolling by Invitation
Not specifiedAll AgesObservationalFrank A. Bucci, Jr., M.D.Investigator-initiated
~25 participants
Updated 2024-10-21 on ClinicalTrials.gov
What's tested:Light Adjustable Lens+
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Satisfaction
Measured over 3-18 months after phacoemulsification
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adults with bilateral pseudophakia who have been implanted with the LAL+ in at least one eye and who have completed LDD light treatments
Sign a written Informed Consent Form
Exclusion
Visually significant eye disease
What this trial measures
- Patient Satisfaction3-18 months after phacoemulsification
Description: Subjective questionnaire explores the frequency/need for glasses for various visual functions at distance/intermediate/near, experience with dysphotopsias, and overall satisfaction of visual function without glasses.